Immunology/Inflammation


The adaptive immune system consists of B and T lymphocytes which mediate humoral immunity (e.g. antibody response) and cell-mediated immunity, respectively. B cell receptor and T cell receptor signaling is responsible for activation of Src family tyrosine kinases, such as Blk, Fyn, and Lyn in B cells and Fyn and Lck in T cells, resulting phosphorylation of the receptor-associated ITAM motifs. Phosphorylated ITAMs serve as the docking sites for Syk family tyrosine kinases, e.g. Syk in B cells and Zap-70 in T cells. Activated Syk kinases then propagate the signals via phosphorylation of downstream proteins. Furthermore, lymphocyte receptor signaling facilitates B and T cell development, differentiation, proliferation and survival.
-
B8781 DeucravacitinibSummary: An orally active TYK2 inhibitor for the treatment of moderate-to-severe plaque psoriasis -
A9909 α-GalactosylceramideSummary: An NKT cell agonist with antitumor and immunomodulatory functions -
B8786 Bromfenac sodium hydrateSummary: An orally active COX inhibitor for ocular inflammation and pain -
B8787 GR 94800 TFASummary: A selective neuropeptide Y Y2 receptor antagonist for energy homeostasis and behavioral regulation -
B8788 Lipoxin A4Summary: An endogenous anti-inflammatory modulator that effectively suppresses inflammatory cytokine production -
B8797 RS 09Summary: A TLR4 agonist adjuvant that enhances vaccine-induced antibody production -
B8906 RU.5211 CitationSummary: An inhibitor that selectively inhibits cGAS activity and blocks cGAMP production and interferon pathway activation -
BA2316 InotuzumabSummary: Inotuzumab (HumanizedAnti-CD22RecombinantAntibody) is humanized, κ-antibody targeted to humans. -
C8541 COX-2-IN-18 -
C8549 PRE-084

